Skip to main content
. 2020 Dec 14;10:21842. doi: 10.1038/s41598-020-78827-9

Table 1.

Binding affinities of the test compounds.

Ki [nM]a
[3H]spiperone
hD2LR hD2SR hD3R hD4R
2a 8.7 ± 2.5 (4) 6.5 ± 1.7 (4) 0.41 ± 0.09 (4) 33 ± 7 (4)
2b 15 ± 5 (3) 6.3 ± 0.2 (3) 1.0 ± 0.2 (3) 120 ± 61 (3)
2c 77 ± 17 (3) 34 ± 8 (3) 13 ± 4 (3) 140 ± 10 (3)
2d 360 ± 60 (4) 350 ± 30 (4) 9.5 ± 1.9 (4) 5,000 ± 300 (4)
4a 5.2 ± 0.6 (4) 1.7 ± 0.3 (5) 0.29 ± 0.02 (5) 27 ± 3 (5)
4b 20 ± 8 (3) 5.1 ± 1.7 (3) 1.9 ± 0.7(3) 59 ± 20 (3)
4c 17 ± 7 (3) 8.4 ± 3.4 (3) 6.5 ± 2.3 (3) 32 ± 6 (3)
4d 7,600 ± 3,000 (4) 6,000 ± 1,400 (4) 11 ± 2 (4)  > 10,000 (4)
7a 3.5 ± 0.4 (8) 1.8 ± 0.2 (8) 0.26 ± 0.03 (8) 8.5 ± 0.8 (8)
8a (NMP64) 1.2 ± 0.2 (4) 0.44 ± 0.12 (4) 0.32 ± 0.05 (4) 10 ± 4 (4)
8b 13 ± 6 (4) 3.6 ± 1.6 (4) 1.9 ± 0.9 (4) 130 ± 10 (4)
10a (NMP160) 46 ± 7 (4) 21 ± 4 (4) 0.97 ± 0.23 (4) 56 ± 4 (4)
10b (NMP137) 10 ± 2 (5) 4.8 ± 1.0 (5) 0.90 ± 0.26 (5) 50 ± 7 (4)
10c (NMP130) 23 ± 5 (4) 15 ± 4 (4) 0.76 ± 0.11 (4) 47 ± 9 (4)

Binding affinities of the test compounds for human D2LR, D2SR, D3R, D4R were determined by radioligand competition.

aData represent mean ± SEM of (n) individual experiments, each performed in triplicates.